Madopar HBS
Madopar HBS is a medicine authorised by Swissmedic under authorisation number 48593. The authorisation holder is Roche Pharma (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 June 1987 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.
| Authorisation number | 48593 |
|---|---|
| Name | Madopar HBS |
| Full name | Madopar HBS, Kapseln |
| Authorisation holder | Roche Pharma (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | not stated |
| First authorisation | 18 June 1987 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Madopar HBS, Kapseln | B | 18 June 1987 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| The Swissmedic export lists no pack sizes for this medicine. | |||||
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Madopar HBS authorised in Switzerland?
Yes. Madopar HBS is authorised by Swissmedic under authorisation number 48593, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Madopar HBS have?
Madopar HBS is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Madopar HBS?
The authorisation holder is Roche Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.